Herv-k blockade to prevent RAS activation in breast cancer
Ended Project Grant Awarded Last action
- Award ID
- R21CA238636
- Recipient
-
Sunnybay Biotech UEI M1F7ZX52AEG3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $339,910
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $179,277 | |
| Amendment | $41,154 | |
| Original award | $119,479 |
Quick answers
Who received award R21CA238636?
R21CA238636 was awarded to Sunnybay Biotech by National Cancer Institute (National Institutes of Health) on May 2, 2019.
How much is award R21CA238636 worth?
$339,910 has been obligated on R21CA238636.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award